We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
80 hedge funds and large institutions have $212M invested in Madrigal Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
94% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 17
33% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 12
4% more funds holding
Funds holding: 77 → 80 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less capital invested
Capital invested by funds: $266M → $212M (-$53.6M)
42% less call options, than puts
Call options by funds: $1.88M | Put options by funds: $3.23M
Holders
80
Holders Change
+3
Holders Change %
+3.9%
% of All Funds
2.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
33
Reduced
17
Closed
12
Calls
$1.88M
Puts
$3.23M
Net Calls
-$1.34M
Net Calls Change
-$1.88M
Top Buyers
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$9.22M |
| 2 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
-$1.79M |
| 3 |
D.E. Shaw & Co
New York
|
-$1.26M |
| 4 |
Renaissance Technologies
New York
|
-$1.12M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$925K |
